Posts

John Kelley Forbes CereMetrix CereScan

CereScan on Forbes: What Radiology Tech Can Learn From Baseball’s Electronic Strike Zone Debate 

Last baseball season when the electronic strike zone idea was once again hotly debated, the striking similarities between the issues baseball and radiology face – accuracy, objectivity, efficiency – became glaringly obvious.

The idea of using technology to increase game consistency and accuracy is a controversial one. The same could be said of the use of automated technologies in radiology. Radiologists fear the introduction of automation and machine learning technologies could make their jobs extinct. However, striking the right balance between human intellect and technology advancements is key to a more successful future.

Whether you’re a physician or an umpire, machine intelligence can provide the information needed to make better, faster decisions. In his latest Forbes.com article, John Kelley, CEO of CereScan and notable tech industry leader, takes a deep dive into how together human and machine have the potential to change the world of healthcare, baseball and beyond.

What Radiology Tech Can Learn From Baseball’s Electronic Strike Zone Debate

Forbes.comJohn Kelley Forbes CereMetrix CereScan – Growing up in St. Louis — arguably the home of the best fanbase in baseball — I quickly became an avid student and player of America’s favorite pastime. Every guy I grew up with playing baseball enjoyed dissecting the technicalities of the game and all the moving parts that come together to form each and every play.

Take the pitcher and the hitter, for example. The matchup would seem to be a simple process of throwing a ball in different ways and having a hitter attempt to successfully make contact. In reality, there is a very complex set of non-verbal processes communicated to each player in the field before any pitch is thrown… Read the full article.

CereScan on Forbes.com: Using Data Analytics to Fight the Opioid Crisis

The opioid crisis statistics are alarming: Drug overdoses, most of which are related to opioids, killed over 64,000 people in the United States last year — an increase of 21% over 2015. Disturbing as those numbers are, understanding the data behind opioid addiction, and analyzing the overwhelming information being collected is critical to fighting the drug crisis.

In the article title “Using Big Data Medical Analytics to Address the Opioid Crisis,” CereScan CEO, John Kelley, discusses how data analytics can and must become a key component in the effort to end the opioid epidemic.

“We’ve all seen the statistics: Drug overdoses, most of which are related to opioids, killed over 64,000 people in the United States last year — an increase of 21% over 2015, according to the CDC. The New York Times just reported that fentanyl has overtaken the top spot from heroin as the leading cause of these deaths. Almost as chilling, there are an estimated 2 million prescription opioid addicts, putting a squeeze on the economy to the tune of more than $75 billion annually.

The national opioid crisis is a dilemma of dichotomies. There are challenges with both prescription and illicit drugs. The solutions must consist of efforts that realistically can reduce the number of people who become addicts in the first place, as well as cure those who do…”

Read the full article on Forbes.com